19-33301036-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004364.5(CEBPA):c.*302C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0151 in 502,302 control chromosomes in the GnomAD database, including 520 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 106 hom., cov: 32)
Exomes 𝑓: 0.018 ( 414 hom. )
Consequence
CEBPA
NM_004364.5 3_prime_UTR
NM_004364.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.28
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 19-33301036-G-A is Benign according to our data. Variant chr19-33301036-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1187270.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEBPA | NM_004364.5 | c.*302C>T | 3_prime_UTR_variant | Exon 1 of 1 | ENST00000498907.3 | NP_004355.2 | ||
CEBPA | NM_001287424.2 | c.*302C>T | 3_prime_UTR_variant | Exon 1 of 1 | NP_001274353.1 | |||
CEBPA | NM_001287435.2 | c.*302C>T | 3_prime_UTR_variant | Exon 1 of 1 | NP_001274364.1 | |||
CEBPA | NM_001285829.2 | c.*302C>T | 3_prime_UTR_variant | Exon 1 of 1 | NP_001272758.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEBPA | ENST00000498907 | c.*302C>T | 3_prime_UTR_variant | Exon 1 of 1 | NM_004364.5 | ENSP00000427514.1 | ||||
ENSG00000267580 | ENST00000589932.1 | n.542-15G>A | intron_variant | Intron 1 of 1 | 2 | |||||
ENSG00000267727 | ENST00000587312.1 | n.-243G>A | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00920 AC: 1400AN: 152194Hom.: 102 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1400
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0176 AC: 6173AN: 349990Hom.: 414 Cov.: 3 AF XY: 0.0184 AC XY: 3329AN XY: 180440 show subpopulations
GnomAD4 exome
AF:
AC:
6173
AN:
349990
Hom.:
Cov.:
3
AF XY:
AC XY:
3329
AN XY:
180440
Gnomad4 AFR exome
AF:
AC:
22
AN:
11026
Gnomad4 AMR exome
AF:
AC:
108
AN:
15238
Gnomad4 ASJ exome
AF:
AC:
46
AN:
11398
Gnomad4 EAS exome
AF:
AC:
4013
AN:
25492
Gnomad4 SAS exome
AF:
AC:
1549
AN:
31366
Gnomad4 FIN exome
AF:
AC:
0
AN:
22450
Gnomad4 NFE exome
AF:
AC:
71
AN:
210224
Gnomad4 Remaining exome
AF:
AC:
361
AN:
21186
Heterozygous variant carriers
0
282
564
846
1128
1410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00923 AC: 1406AN: 152312Hom.: 106 Cov.: 32 AF XY: 0.0110 AC XY: 818AN XY: 74476 show subpopulations
GnomAD4 genome
AF:
AC:
1406
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
818
AN XY:
74476
Gnomad4 AFR
AF:
AC:
0.00137092
AN:
0.00137092
Gnomad4 AMR
AF:
AC:
0.0079054
AN:
0.0079054
Gnomad4 ASJ
AF:
AC:
0.00345622
AN:
0.00345622
Gnomad4 EAS
AF:
AC:
0.169636
AN:
0.169636
Gnomad4 SAS
AF:
AC:
0.0602235
AN:
0.0602235
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00019112
AN:
0.00019112
Gnomad4 OTH
AF:
AC:
0.0170455
AN:
0.0170455
Heterozygous variant carriers
0
65
131
196
262
327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
508
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 24, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at